The spectrum of primary liver cancers: heterogeneity and continuity. A foundation for diagnosis and treatment of cancer

Mina Komuta^{1

2}, Akihisa Ueno^{2

3}, Michiie Sakamoto²

Affiliations

¹ Department of Pathology, International University of Health and Welfare, School of Medicine , Narita Hospital , Chiba , Japan.
² Department of Pathology , Keio University School of Medicine , Tokyo , Japan.
³ Division of Diagnostic Pathology , Keio University School of Medicine , Tokyo , Japan.

Editorial

Mina Komuta et al. Hepatology. 2023.

. 2023 Jan 1;77(1):10-12.

doi: 10.1002/hep.32452. Epub 2022 Mar 28.

Mina Komuta^{1

2}, Akihisa Ueno^{2

3}, Michiie Sakamoto²

¹ Department of Pathology, International University of Health and Welfare, School of Medicine , Narita Hospital , Chiba , Japan.
² Department of Pathology , Keio University School of Medicine , Tokyo , Japan.
³ Division of Diagnostic Pathology , Keio University School of Medicine , Tokyo , Japan.

No abstract available

Comment on

Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma.
Jeon Y, Kwon SM, Rhee H, Yoo JE, Chung T, Woo HG, Park YN. Jeon Y, et al. Hepatology. 2023 Jan 1;77(1):92-108. doi: 10.1002/hep.32397. Epub 2022 Feb 26. Hepatology. 2023. PMID: 35124821

1. Nakanuma Y, Klimstra D, Komuta M, Zen Y. Intrahepatic cholangiocarcinoma. In: WHO Classification of Tumours Editorial Board, ed. Digestive System Tumours: WHO Classification of Tumours. 5th ed. IARC; 2019:254–9.
1. Jeon Y, Kwon SM, Rhee H, Yoo JE, Chung T, Woo HG, et al. Molecular and radiopathologic spectrum between HCC and intrahepatic cholangiocarcinoma. Hepatology. 2023;77:92–108.
1. Komuta M, Spee B, Borght SV, De Vos R, Verslype C, Aerts R, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008;47(5):1544–56.
1. Komuta M, Govaere O, Vandecaveye V, Akiba J, Van Steenbergen W, Verslype C, et al. Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes. Hepatology. 2012;55(6):1876–88.
1. Govaere O, Komuta M, Berkers J, Spee B, Janssen C, de Luca F, et al. Keratin 19: a key role player in the invasion of human hepatocellular carcinomas. Gut. 2014;63(4):674–85.